Compare Liquidia Corporation Common Stock (LQDA) vs Standard Lithium Ltd (SLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs Standard Lithium Ltd — how do they compare? Liquidia Corporation Common Stock trades at $33.94 (market cap $3.04B), while Standard Lithium Ltd trades at $1.33 (market cap $345.40M). The key difference: Liquidia Corporation Common Stock is far larger — about 8.8× Standard Lithium Ltd's market cap, and Liquidia Corporation Common Stock is trading nearer its 52-week high, Standard Lithium Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Standard Lithium Ltd for 24 Days on average.
| LQDA | SLI | |
|---|---|---|
Market Cap | $3.04B | $345.40M |
Volume | 21,111,778 | 2,580,587 |
Sector | Health | Basic Materials |
52-Week High | $91.03 | $5.65 |
52-Week Low | $22.02 | $1.38 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $2.94B | $208.31M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Standard Lithium (SLI) trades at $1.43, down 4.03% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company reported no revenue in 2025, a net loss of $48.40 million, and negative cash flow from operations, though it secured significant financing. Key developments include progress toward a final investment decision for its Arkansas lithium project in 2026 and new offtake agreements, signaling potential future revenue streams.
The investment outlook is speculative, hinging on successful project execution and future lithium production. While analyst consensus is strongly bullish with a $3.83 price target, high execution risk and current lack of revenue present significant challenges. The stock offers high-risk, high-reward potential for investors betting on the company's transition to a lithium producer.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →
